<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.5 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>5</IssueIDStart>

               <IssueIDEnd>5</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>5</Month>

                     <Day>31</Day>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>5</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="De" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460305.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050256</ArticleDOI>

                  <ArticleTitle Language="De">Strategien zur Gentherapie des Melanoms</ArticleTitle>

                  <ArticleSubTitle Language="De"/>

                  <ArticleCategory>AKTUELLERKOMMENTAR</ArticleCategory>

                  <ArticleFirstPage>305</ArticleFirstPage>

                  <ArticleLastPage>308</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Reinhard</GivenName>

                           <FamilyName>Dummer</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Azita</GivenName>

                           <FamilyName>Davis-Daneshfar</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A2">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Christian</GivenName>

                           <FamilyName>Döhring</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Udo</GivenName>

                           <FamilyName>Döbbeling</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Günter</GivenName>

                           <FamilyName>Burg</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Dermatologische Klinik (Direktor: Prof. Dr. G. Burg), Universitätsspital, Zürich
 </OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>XX</Country>

                        </OrgAddress>

                     </Affiliation>

                     <Affiliation ID="A2">

                        <OrgName>Basel Institute for Immunology, Basel (founded and supported by Hoffmann-LaRoche, Basel, Switzerland)
 </OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>CH</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung</Heading>

                     <Para/>

                     <Para>

                        <Emphasis Type="Italic">Nachdem die aktive unspezifische Immuntherapie adjuvant und palliativ die Überlebenszeiten von Melanompatienten günstig beeinflußt hat, bietet jetzt die Gentherapie die Möglichkeit einer aktiven spezifischen Immuntherapie. Sie beinhaltet einen Gentransfer, der viral oder nicht-viral, in vivo oder ex vivo erfolgen kann. Für das Melanom bieten sich an: Vakzinierung mit Tumor-spezifischen, HLA-assoziierten Antigenen mittels Peptiden oder „naked DNA“, Vakzinierung mit Melanomzellen, die mit einem Zytokingen oder mit B7 transfiziert wurden, adoptive Immuntherapie mit in vitro propagierten spezifischen T-Zellen, transfizierten Tumor-infiltrierenden Lymphozyten, oder Transfektion der Tumorzellen in vivo mit einem Tumorsuppressorgen, dessen Dysfunktion im Melanom eine zentrale Rolle spielt.</Emphasis>

                     </Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Summary</Heading>

                     <Para/>

                     <Para>Active unspecific immunotherapy in an adjuvant or palliative setting has been shown to enhance survival in melanoma patients, and gene therapy now offers new perspectives for active specific immunotherapy. Gene therapy includes the transfer of genetic material performed by either viral or non-viral methods and in vivo or ex vivo. For melanoma the following approaches are suggested: vaccination with tumour-specific, HLA-associated antigens using peptides or `naked DNA', vaccination with melanoma cells transfected with cytokine genes or B7, adoptive immunotherapy with specific T-lymphocytes or transfected tumour-infiltrating lymphocytes, or transfection of tumour cells with a tumour suppressor gene whose dysfunction plays a crucial role in melanoma.
 </Para>

                  </Abstract>

                  <KeywordGroup Language="De">

                     <Keyword>Schlüsselwörter Melanom</Keyword>

                     <Keyword>Immuntherapie</Keyword>

                     <Keyword>Gentherapie</Keyword>

                     <Keyword>Zytokine</Keyword>

                     <Keyword>Tumorinfiltrierende Lymphozyten</Keyword>

                     <Keyword>B7</Keyword>

                     <Keyword>Tumorsuppressoren</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words Melanoma</Keyword>

                     <Keyword>Immunotherapy</Keyword>

                     <Keyword>Gene therapy</Keyword>

                     <Keyword>Cytokines</Keyword>

                     <Keyword>Tumour-infiltrating lymphocytes</Keyword>

                     <Keyword>B7</Keyword>

                     <Keyword>Tumour-suppressor gene</Keyword>

                  </KeywordGroup>

                  <ArticleNote Type="Misc">

                     <SimplePara>Eingegangen am 20. 10. 1994 Angenommen am 11. 01. 1995</SimplePara>

                  </ArticleNote>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>